New tool aims to help lung cancer patients navigate tough choices

NCT ID NCT04946279

Ongoing Symptom relief Sponsor: OHSU Knight Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a conversation tool designed to help people with lung cancer understand their options and make decisions that match their values. About 98 patients will use the tool during their care. The goal is to see if it reduces anxiety, regret, and confusion, and improves satisfaction with their treatment choices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: conversation tool (decision aid)
What this could lead to: If it works, this tool could help lung cancer patients feel more informed and involved in their treatment decisions, potentially reducing anxiety and regret.
What could go wrong: This is a small, early-stage feasibility study with only 98 participants. The tool may not show clear benefits, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG NON-SMALL CELL CARCINOMA STAGE I LUNG CANCER AJCC V8 STAGE II LUNG CANCER AJCC V8 STAGE III LUNG CANCER AJCC V8 STAGE IV LUNG CANCER AJCC V8

New tool aims to help lung cancer patients navigate tough choices

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions